Clinical Experience with Simvastatin Compared with Cholestyramine

This publication has 11 references indexed in Scilit:

• COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA
  The Lancet, 1988
• Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia
  Atherosclerosis, 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia
  Annals of Internal Medicine, 1987
• Complementarity of Colestipol, Niacin, and Lovastatin in Treatment of Severe Familial Hypercholesterolemia
  Annals of Internal Medicine, 1987
• Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro
  European Journal of Clinical Investigation, 1987
• Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
• Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
  Journal of Clinical Investigation, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
  Proceedings of the National Academy of Sciences, 1980